{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:23:49Z","timestamp":1794029029845,"version":"4.8.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":194,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001721","name":"University of Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101001678"],"award-info":[{"award-number":["101001678"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003245","name":"Ministerie van Onderwijs, Cultuur en Wetenschap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","award":["VI.C.202.022"],"award-info":[{"award-number":["VI.C.202.022"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","award":["024.003.001"],"award-info":[{"award-number":["024.003.001"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","award":["KICH1.LWV04.21.013"],"award-info":[{"award-number":["KICH1.LWV04.21.013"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","award":["016.176.640"],"award-info":[{"award-number":["016.176.640"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.101069","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:49:34Z","timestamp":1784764174000},"page":"101069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the Immortalized Primary Human Hepatocyte Cell Line Fa2N-4 as a Model for Metabolic Dysfunction\u2013Associated Steatotic Liver Disease"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8971-4370","authenticated-orcid":false,"given":"Victoria E.J.M.","family":"Palasantzas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dicky","family":"Struik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trijnie","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam H.","family":"Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Gelderloos-Arends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen R.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista K.","family":"van Dijk-Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebo","family":"Withoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne A.","family":"Hoogerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2026.101069_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.101069_bib2","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastha.2026.101069_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.gastha.2026.101069_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.gastha.2026.101069_bib5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.clinbiochem.2015.06.023","article-title":"Gut-liver axis, nutrition, and non-alcoholic fatty liver disease","volume":"48","author":"Kirpich","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.gastha.2026.101069_bib6","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1136\/gutjnl-2021-326874","article-title":"Current therapies and new developments in NASH","volume":"71","author":"Dufour","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.gastha.2026.101069_bib7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41587-024-02220-4","article-title":"FDA approves first MASH drug","volume":"42","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.gastha.2026.101069_bib8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastha.2026.101069_bib9","series-title":"FDA approves treatment for serious liver disease known as \u2018MASH\u2019","year":"2025"},{"key":"10.1016\/j.gastha.2026.101069_bib10","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction\u2013associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastha.2026.101069_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastha.2026.101069_bib12","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s42255-024-01043-6","article-title":"An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"6","author":"Vacca","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.gastha.2026.101069_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103549","article-title":"In vitro models for non-alcoholic fatty liver disease: emerging platforms and their applications","volume":"25","author":"Ramos","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.gastha.2026.101069_bib14","doi-asserted-by":"crossref","first-page":"8791","DOI":"10.3390\/ijms24108791","article-title":"Comparative transcriptomic analysis of three common liver cell lines","volume":"24","author":"Arzumanian","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gastha.2026.101069_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/nu15010040","article-title":"A comparison of primary human hepatocytes and hepatoma cell lines to model the effects of fatty acids, fructose and glucose on liver cell lipid accumulation","volume":"15","author":"Huggett","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.gastha.2026.101069_bib16","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jhep.2022.03.031","article-title":"Rare ATG7 genetic variants predispose patients to severe fatty liver disease","volume":"77","author":"Baselli","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101069_bib17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.mehy.2015.10.019","article-title":"Adiponutrin (PNPLA3) in liver fibrogenesis: is unaltered HepG2 cell line a better model system compared to murine models?","volume":"85","author":"Dutta","year":"2015","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.gastha.2026.101069_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1124\/jpet.103.061713","article-title":"Induction of drug metabolism enzymes and MDR1 using a novel human hepatocyte cell line","volume":"309","author":"Mills","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.gastha.2026.101069_bib19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1080\/00498250802495846","article-title":"Efficient assessment of the utility of immortalized Fa2N-4 cells for cytochrome P450 (CYP) induction studies using multiplex quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and substrate cassette methodologies","volume":"38","author":"Kenny","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.gastha.2026.101069_bib20","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1124\/dmd.106.010132","article-title":"Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caused by CYP3A4 induction","volume":"34","author":"Ripp","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.gastha.2026.101069_bib21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jhep.2014.05.046","article-title":"Strategies for immortalization of primary hepatocytes","volume":"61","author":"Ramboer","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101069_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/cells13080703","article-title":"Establishment and characterization of SV40 T-antigen immortalized porcine muscle satellite cell","volume":"13","author":"Ni","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.gastha.2026.101069_bib23","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1093\/nar\/gkh887","article-title":"Transcriptional control of SV40 T-antigen expression allows a complete reversion of immortalization","volume":"32","author":"May","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gastha.2026.101069_bib24","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1124\/dmd.108.020677","article-title":"Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction","volume":"36","author":"Hariparsad","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.gastha.2026.101069_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.trsl.2016.08.006","article-title":"Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress","volume":"180","author":"Li","year":"2017","journal-title":"Translational Res"},{"key":"10.1016\/j.gastha.2026.101069_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal Biochem"},{"key":"10.1016\/j.gastha.2026.101069_bib27","series-title":"Encyclopedia of lipidomics","first-page":"1","article-title":"Liquid extraction: bligh and dyer","author":"S\u00fcndermann","year":"2016"},{"issue":"1","key":"10.1016\/j.gastha.2026.101069_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.gastha.2026.101069_bib29","series-title":"Cell detection with star-convex polygons","first-page":"265","author":"Schmidt","year":"2018"},{"key":"10.1016\/j.gastha.2026.101069_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.gastha.2026.101069_bib31","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1101\/gr.6202607","article-title":"A systems biology approach for pathway level analysis","volume":"17","author":"Draghici","year":"2007","journal-title":"Genome Res"},{"key":"10.1016\/j.gastha.2026.101069_bib32","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1101\/gr.153551.112","article-title":"Analysis and correction of crosstalk effects in pathway analysis","volume":"23","author":"Donato","year":"2013","journal-title":"Genome Res"},{"key":"10.1016\/j.gastha.2026.101069_bib33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.gastha.2026.101069_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/23962","article-title":"Both Rb\/p16(INK4a) inactivation and telomerase activity are required to immortalize human epithelial cells","volume":"396","author":"Kiyono","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.gastha.2026.101069_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.onc.1205014","article-title":"Comparison of human mammary epithelial cells immortalized by simian virus 40 T-antigen or by the telomerase catalytic subunit","volume":"21","author":"Toouli","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.gastha.2026.101069_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14750","article-title":"An immortalized adult human erythroid line facilitates sustainable and scalable generation of functional red cells","volume":"8","author":"Trakarnsanga","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.gastha.2026.101069_bib37","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2015.08.011","article-title":"Heritability of hepatic fibrosis and steatosis based on a prospective twin study","volume":"149","author":"Loomba","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101069_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.gastha.2026.101069_bib39","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/hep.26440","article-title":"Characterization of european-ancestry NAFLD-associated variants in individuals of African and Hispanic descent","volume":"58","author":"Palmer","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2026.101069_bib40","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1093\/nar\/gkz169","article-title":"Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gastha.2026.101069_bib41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.dld.2021.06.015","article-title":"PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center","volume":"54","author":"Balcar","year":"2022","journal-title":"Dig Liver Dis"},{"issue":"10","key":"10.1016\/j.gastha.2026.101069_bib42","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41588-023-01497-6","article-title":"Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/j.gastha.2026.101069_bib43","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.cgh.2024.05.052","article-title":"Genetics of metabolic dysfunction-associated steatotic liver disease: the state of the art update","volume":"22","author":"Sookoian","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.gastha.2026.101069_bib44","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.gastha.2026.101069_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/gpbjnl\/qzae031","article-title":"Genome-wide studies reveal genetic risk factors for hepatic fat content","volume":"22","author":"Li","year":"2024","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.gastha.2026.101069_bib46","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","article-title":"ClinGen \u2014 the clinical genome resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastha.2026.101069_bib47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.gastha.2026.101069_bib48","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1016\/j.cell.2022.08.004","article-title":"High-coverage whole-genome sequencing of the expanded 1000 genomes project cohort including 602 trios","volume":"185","author":"Byrska-Bishop","year":"2022","journal-title":"Cell"},{"issue":"Suppl 1","key":"10.1016\/j.gastha.2026.101069_bib49","first-page":"S80","article-title":"Rare variants, common markers: synthetic association and beyond","volume":"35","author":"Kent","year":"2011","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.gastha.2026.101069_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.14336\/AD.2023.0530","article-title":"Human APOE4 protects high-fat and high-sucrose diet fed targeted replacement mice against fatty liver disease compared to APOE3","volume":"15","author":"Huebbe","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.gastha.2026.101069_bib51","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1080\/15548627.2017.1319544","article-title":"The constitutive lipid droplet protein PLIN2 regulates autophagy in liver","volume":"13","author":"Tsai","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.gastha.2026.101069_bib52","first-page":"355","article-title":"Use of resmetirom in patients with metabolic dysfunction-associated steatohepatitis","volume":"20","author":"Harrison","year":"2024","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.gastha.2026.101069_bib53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrendo.2018.10","article-title":"Direct effects of thyroid hormones on hepatic lipid metabolism","volume":"14","author":"Sinha","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.gastha.2026.101069_bib54","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.3390\/ijms24065843","article-title":"Resmetirom ameliorates NASH-model mice by suppressing STAT3 and NF-\u03baB signaling pathways in an RGS5-dependent manner","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gastha.2026.101069_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208756","article-title":"Tumor suppressor RARRES1- a novel regulator of fatty acid metabolism in epithelial cells","volume":"13","author":"Maimouni","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.gastha.2026.101069_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6346(03)00115-3","article-title":"Connective tissue growth factor (CTGF\/CCN2) in hepatic fibrosis","volume":"26","author":"Rachfal","year":"2003","journal-title":"Hepatol Res"},{"issue":"4","key":"10.1016\/j.gastha.2026.101069_bib57","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12072-019-09960-5","article-title":"CCN2\u2013MAPK\u2013Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma","volume":"13","author":"Liao","year":"2019","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.gastha.2026.101069_bib58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13287-017-0747-3","article-title":"Hepatic stem cells with self-renewal and liver repopulation potential are harbored in CDCP1-positive subpopulations of human fetal liver cells","volume":"9","author":"Zhang","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.gastha.2026.101069_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.873","article-title":"CD44 is involved in liver regeneration through enhanced uptake of extracellular cystine","volume":"12","author":"Kim","year":"2022","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.gastha.2026.101069_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/srep39182","article-title":"CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPAR\u03b1","volume":"6","author":"Nakagawa","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.gastha.2026.101069_bib61","article-title":"A human single-cell atlas identifies OLR1+ scar-associated macrophages as a therapeutic target for chronic liver disease","author":"Papachristoforou","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.gastha.2026.101069_bib62","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s12672-025-02638-5","article-title":"Unveiling the role of IL7R in metabolism-associated fatty liver disease leading to hepatocellular carcinoma through transcriptomic and machine learning approaches","volume":"16","author":"Annadurai","year":"2025","journal-title":"Discov Oncol"},{"key":"10.1016\/j.gastha.2026.101069_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02332-23","article-title":"Autophagy gene-dependent intracellular immunity triggered by interferon-\u03b3","volume":"14","author":"McAllaster","year":"2023","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.gastha.2026.101069_bib64","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1038\/s41467-024-49633-y","article-title":"IFN\u03b3-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease","volume":"15","author":"Friedline","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.gastha.2026.101069_bib65","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1038\/s41467-021-24632-5","article-title":"Intracellular lipid droplet accumulation occurs early following viral infection and is required for an efficient interferon response","volume":"12","author":"Monson","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.gastha.2026.101069_bib66","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13532","article-title":"In vitro cellular models of human hepatic fatty acid metabolism: differences between Huh7 and HepG2 cell lines in human and fetal bovine culturing serum","volume":"5","author":"Gunn","year":"2017","journal-title":"Physiol Rep"},{"key":"10.1016\/j.gastha.2026.101069_bib67","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jhep.2023.09.020","article-title":"SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease","volume":"80","author":"Salomone","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101069_bib68","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/hep.30350","article-title":"17-Beta hydroxysteroid dehydrogenase 13 is a hepatic retinol dehydrogenase associated with histological features of nonalcoholic fatty liver disease","volume":"69","author":"Ma","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2026.101069_bib69","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ajg.2018.1","article-title":"The rs626283 variant in the MBOAT7 gene is associated with insulin resistance and fatty liver in Caucasian obese youth","volume":"113","author":"Umano","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101069_bib70","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101069_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313135","article-title":"The curious case of the HepG2 cell line: 40 years of expertise","volume":"22","author":"Arzumanian","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gastha.2026.101069_bib72","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s42003-022-04046-9","article-title":"A comprehensive transcriptomic comparison of hepatocyte model systems improves selection of models for experimental use","volume":"5","author":"Ardisasmita","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.gastha.2026.101069_bib73","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/nu18030388","article-title":"Assessing nutraceuticals for hepatic steatosis: a standardized in vitro approach","volume":"18","author":"Palasantzas","year":"2026","journal-title":"Nutrients"},{"key":"10.1016\/j.gastha.2026.101069_bib74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.18632\/aging.101067","article-title":"Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver disease (NAFLD) in humans","volume":"9","author":"Liu","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.gastha.2026.101069_bib75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jgh.12714","article-title":"Common variant in the glucokinase regulatory gene rs780094 and risk of nonalcoholic fatty liver disease: a meta-analysis","volume":"30","author":"Zain","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.101069_bib76","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1038\/s41591-023-02602-2","article-title":"An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease","volume":"29","author":"Kendall","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.gastha.2026.101069_bib77","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000820","article-title":"Paired snRNA-seq and scRNA-seq analysis of MASLD patients to identify early-stage markers for disease progression","volume":"9","author":"Park","year":"2025","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.gastha.2026.101069_bib78","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2024.06.040","article-title":"Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease","volume":"82","author":"Kwon","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101069_bib79","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3390\/cells10081883","article-title":"Long non-coding RNAs involved in progression of non-alcoholic fatty liver disease to steatohepatitis","volume":"10","author":"Atanasovska","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.gastha.2026.101069_bib80","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/biomedicines10051020","article-title":"Comparative transcriptome analysis reveals that Exendin-4 improves steatosis in HepG2 cells by modulating signaling pathways related to lipid metabolism","volume":"10","author":"Errafii","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.gastha.2026.101069_bib81","series-title":"Probiotic potential and antimicrobial activity of Bacteroidales strains to fight fatty liver disease","author":"de la Morena","year":"2024"},{"key":"10.1016\/j.gastha.2026.101069_bib82","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hep.31296","article-title":"Thyroid hormone signaling and the liver","volume":"72","author":"Ritter","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2026.101069_bib83","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jhep.2024.10.018","article-title":"Thyroid hormone receptor-\u03b2 analogues for the treatment of metabolic dysfunction-associated steatohepatitis (MASH)","volume":"82","author":"Ratziu","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101069_bib84","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/j.jhep.2025.03.022","article-title":"Resmetirom directly inhibits lipid accumulation in human liver-derived organoids","volume":"83","author":"Li","year":"2025","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.gastha.2026.101069_bib85","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00418-020-01898-2","article-title":"Divergence exists in the subcellular distribution of intramuscular triglyceride in human skeletal muscle dependent on the choice of lipid dye","volume":"154","author":"Strauss","year":"2020","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.gastha.2026.101069_bib86","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1432-1033.1976.tb10827.x","article-title":"Effects of thyroid hormone deficiency on the distribution of hepatic metabolites and control of pathways of carbohydrate metabolism in liver and adipose tissue of the rat","volume":"68","author":"Baquer","year":"1976","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.gastha.2026.101069_bib87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1432-1033.1987.tb11009.x","article-title":"Regulation of hepatic glucokinase gene expression: role of carbohydrates, and glucocorticoid and thyroid hormones","volume":"164","author":"Minderop","year":"1987","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.gastha.2026.101069_bib88","doi-asserted-by":"crossref","first-page":"C624","DOI":"10.1152\/ajpcell.00336.2016","article-title":"Is it time to reinvent basic cell culture medium?","volume":"312","author":"Mc Kee","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.gastha.2026.101069_bib89","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/labinvest.3700590","article-title":"Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes","volume":"87","author":"de Gottardi","year":"2007","journal-title":"Lab Invest"},{"key":"10.1016\/j.gastha.2026.101069_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-15-1108","article-title":"RNA-Seq gene expression profiling of HepG2 cells: the influence of experimental factors and comparison with liver tissue","volume":"15","author":"Tyakht","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.gastha.2026.101069_bib91","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00204-016-1745-4","article-title":"A multicenter assessment of single-cell models aligned to standard measures of cell health for prediction of acute hepatotoxicity","volume":"91","author":"Sison-Young","year":"2017","journal-title":"Arch Toxicol"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:24:19Z","timestamp":1794025459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326001901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":91,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326001901"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101069","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Immortalized Primary Human Hepatocyte Cell Line Fa2N-4 as a Model for Metabolic Dysfunction\u2013Associated Steatotic Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101069"}}